Your request has been received by DRG. A represantative will contact you shortly to provide more details on the research and data contained in this report and ensure that it will meet your current research needs.
The Latin American market for aesthetic injectables will show strong growth through 2027. Although some factors—such as weak currencies and strict regulations in some countries—will have a negative impact in the short term, high levels of aesthetic consciousness and improving economic conditions in the region will lead to sustained revenue growth over the forecast period.
This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for aesthetic injectables in Latin America across a 10-year period.
The dermal filler market will be the fastest-growing segment of the aesthetic injectable market over the forecast period.
What factors will drive this growth?
How will varying preference across the region affect the dermal filler markets in each of the countries covered?
Large MNCs will maintain their dominant positions in the market over the forecast period.
How do the most established competitors in this market maintain market share?
What strategies can new competitors employ to gain entry into the Latin American aesthetic injectable market?
Regulations for aesthetic procedures are getting stricter due to safety concerns.
Which product category is being impacted by safety concerns?
Which countries are most impacted by these concerns?
Aesthetic injectable procedure volumes will grow due to high aesthetic consciousness across Latin American region.
What major factors are contributing to growth over the forecast period?
Which aesthetic injectable procedures are most popular in the Latin American region, and which procedures will experience the fastest growth through 2027?
Already a Client? Log in to access this report.
Diwakar Bahuguna is a research associate within the Orthopedics Medtech Insights team at Decision Resources Group. Diwakar holds a Bachelor's degree in Pharmacy from the Delhi Institute of Pharmaceutical Sciences and Research and an MBA in Pharmaceutical Management from the National Institute of Pharmaceutical Education and Research, Mohali.